Clinical Trial Update: A Study to Learn How Well the Drug Vericiguat Works and How Safe it is Under Real World Conditions in Indian Participants After Worsening of a Long-term Heart Condition in Which the Left Side of the Heart Does Not Pump Blood as Well as it Should (Chronic Heart Failure With Reduced Ejection Fraction) [Phase 4]

View source ↗

Summary

Phase 4 real-world study to evaluate the effectiveness and safety of vericiguat in Indian participants with chronic heart failure with reduced ejection fraction…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Reduced Ejection Fraction

Drugs mentioned

• Vericiguat (vericiguat)

Snippet

Sponsor: Bayer | Conditions: Chronic Heart Failure With Reduced Ejection Fraction, Worsening Heart Failure | Phase 4 | Status: COMPLETED